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Abstract: Full-term human umbilical cord contains three blood vessels: two arteries coiled around a vein and
surrounded by Wharton’s jelly, a mucous tissue with few mesenchymal stromal cells and abundant extracellular
matrix. Umbilical vessels lack innervations, thus endothelial cells must play a role in the control of blood flow.
The aim of this study was to investigate in human umbilical cord the expression of five peptides that could be
involved in the regulation of vascular tone: Orphanin FQ, Oxytocin, Atrial Natriuretic Peptide (ANP), endothe-
lial Nitric Oxide Synthase (eNOS) and inducible Nitric Oxide Synthase (iNOS). The expression of these mole-
cules in full-term human umbilical cord was investigated through immunohistochemistry and RT-PCR. Immu-
noreactivity for Orphanin FQ was detected in Wharton’s jelly, vessel musculature and endothelium; Oxytocin,
ANP and eNOS were expressed by the umbilical epithelium, Wharton’s jelly and endothelium, whereas iNOS
only by endothelial cells. RT-PCR analysis showed transcriptional expression of Oxytocin, ANP and eNOS
mRNAs. The presence of Orphanin, Oxytocin, ANP, eNOS and iNOS proteins was identified in the human
umbilical cord. mRNA expression for Oxytocin, ANP and eNOS suggest that these molecules are synthesized by
umbilical cord cells themselves. The expression of these vasoactive molecules could be part of a general mech-
anism locally regulating vascular tone. (Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 2, pp. X–X)
Key words: human umbilical cord, Orphanin, Oxytocin, ANP, eNOS, iNOS
Introduction
The umbilical cord is the organ connecting the fetus
to the placenta, responsible for the transport of blood
and nourishment to the fetus. Three blood vessels can
be identified in the full-term human umbilical cord
(Figure 1); two arteries coiled around a vein: these
vessels are surrounded by Wharton’s jelly, a mucous
tissue composed of a few mesenchymal stromal cells
and an abundant extracellular matrix rich in water,
glycosaminoglycans, proteoglycans and collagen fibers
[1, 2]. Most current knowledge of the ultrastructure
of the umbilical cord derives from electron microsco-
py studies carried out in the 1970s.
Human umbilical cord epithelium was described
for the first time by Hoyes; its structure is very simi-
lar to that of the fetal epidermis with the exception
that it is not keratinized. It is composed of one to five
layers of flattened cells, with some of the superficial cells
lacking nuclei and organelles, and their cytoplasm con-
taining a loose meshwork of filamentous material [3].
The endothelium of umbilical blood vessels (both
vein and arteries) consists of a single layer of endot-
helial cells, whose cytoplasm is rich in mitochondria,
endoplasmic reticulum and Golgi apparatus, and con-
tains large deposits of glycogen and Weibel & Palade
bodies [4].
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Parry described the morphology of Wharton’s jel-
ly mesenchymal cells: these cells are elongated with
thin, long processes extending from the cell body; they
have a well developed rough endoplasmic reticulum
and Golgi apparatus, indicating an intense activity of
protein synthesis and secretion [5]. Wharton’s jelly
mesenchymal cells are similar both to fibroblasts and
smooth muscle cells and are therefore considered as
myo-fibroblasts [6, 7]. These stromal cells express both
muscle-specific contractile proteins, such as actin,
myosin, desmin and a-smooth muscle actin [6, 8], and
mesenchymal stem cell (MSCs) markers, such as
CD105, CD73 and CD90, while they do not express
hematopoietic stem cell markers [9]. Based on this
evidence, it is realistic to assume that umbilical cord
stromal cells contain more than one set of stem cell
population; in agreement with this hypothesis, um-
bilical cord stromal cells have been successfully dif-
ferentiated into adipocytes, chondrocytes, osteocytes,
cardiomyocytes and skeletal myocytes in vitro [10–
12], as well as partially differentiated into neurons,
glial cells and endothelial cells both in vitro and in
vivo [13, 14].
In this study, we investigated, by immunohis-
tochemistry and RT-PCR, the expression of Orpha-
nin, Oxytocin, Atrial Natriuretic Peptide, endothelial
Nitric Oxide Synthase and inducible Nitric Oxide Syn-
thase in full-term human umbilical cord.
Orphanin FQ is a peptide mainly involved in the
mediation and modulation of pain; intracerebroven-
tricular injection of Orphanin into a mouse brain has
hyperalgesic effects [15, 16]. Orphanin has been
shown to be involved in anxiety, stress, memory, learn-
ing, locomotor activity, tolerance, dependence and
withdrawal phenomena and it also has a role in va-
sorelaxation; it causes hypotension and vasodilatation.
Oxytocin is synthesized in magnocellular neuro-
secretory cells of supraoptic and paraventricular nu-
clei of the hypothalamus and is released by the pitu-
itary gland. Based on its functions, it can be consid-
ered to be both a hormone and a neurotransmitter;
as a hormone, it stimulates uterine contractions dur-
ing labor and milk production in breastfeeding, and,
due to its similarity to vasopressin, can reduce the
excretion of urine and stimulate sodium excretion. As
a neurotransmitter, Oxytocin has a role in social be-
havior in many species; it is involved in bonding, ma-
ternal behavior, sexual arousal, increasing trust and
reducing fear [17, 18]; it also has anti-stress functions:
for example it reduces blood pressure and cortisol
levels, increases tolerance to pain and reduces anxi-
ety.
Atrial Natriuretic Peptide (ANP) is synthesized by
atrial myocytes and released in response to high blood
pressure, atrial distension, sympathetic stimulation of
b-adrenoreceptors, high sodium concentration, angio-
tensin-II and endothelin. Its function is to reduce
blood pressure through the reduction of water and
sodium in the circulatory system, but it also has vas-
cular effects: it relaxes vascular smooth muscles in
arterioles and venules.
Nitric Oxide Synthase (NOS) is the enzyme re-
sponsible for the synthesis of nitric oxide (NO), a
molecule involved in vasorelaxation, neurotransmis-
sion and cytotoxicity. Three isoforms exist: endothe-
lial NOS (eNOS), inducible NOS (iNOS) and neu-
ronal NOS (nNOS). eNOS is the constitutive isoform
expressed mainly by endothelial cells; it provides a
basal level of nitric oxide and has a pivotal role in
vasorelaxation, platelet aggregation and the mecha-
nisms of cardiovascular homeostasis. iNOS is the in-
ducible isoform expressed by macrophages and is ac-
tivated by inflammatory signals such as cytokines, in-
terferon-g and oxidative stresses.
Umbilical cord blood vessels lack any innervations,
thus endothelial cells must play a major role in the
local control of blood flow [19]; this prompted us to
investigate the expression of some peptides involved
in the regulation of vascular tone: we studied the ex-
pression and localization of Orphanin FQ, Oxytocin,
ANP, eNOS and iNOS in full-term human umbilical
cords by immunohistochemistry and RT-PCR.
Figure 1. Azan staining of a section of full-term human
umbilical cord. a — amniotic epithelium; b — sub-amniotic
Wharton’s jelly; c — inner Wharton’s jelly; d–e — circular
and longitudinal layers of vascular musculature; f —
vascular endothelium; ua — umbilical artery; uv —
umbilical vein, bar 1,8 mm
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Samples. The analysis was performed on 15 full-term hu-
man umbilical cords obtained by cesarean section. The
umbilical cords were provided by the Gynecology and Ob-
stetrics clinic of the Paolo Giaccone University Hospital in
Palermo. Human gingival mucosa samples used as positive
controls were provided by the Odontostomatological clinic
of the same hospital. Informed consent was obtained from
patients a few days before surgery. The experiment was
approved by the local Ethics Committee.
Animals. Rat tissue samples, used as positive controls for some
of our immunohistochemical experiments, were obtained from
male Wistar rats (four months old). Animals were housed three
to a cage in plastic cages lined with wood chips, alternating 12
h light/dark periods (lights on 6 am–6 pm) in a temperature
(24 ± 2°C) and humidity-controlled room. The rats had free
access to water and food. Before being sacrificed, rats were
anesthetized by intraperitoneal injection of chloralose. Ani-
mal experiments were performed in accordance with the Eu-
ropean Communities Council Directive (86/609/EEC). All ap-
propriate measures were taken to minimize pain or discom-
fort to the animals. Brains, hearts and aorta were dissected.
Immunohistochemistry. Tissue samples (human gingiva,
rat tissues or human umbilical cord sections) were forma-
lin-fixed, dehydrated in a series of alcohols, clarified in
xylene and paraffin-embedded. Sections of 7 μm were cut
with a Leica microtome RM2145, dried overnight at 37°C
and then stored at room temperature until use; prior to
immunostaining, slides were de-waxed in xylene, re-hydrat-
ed in a series of alcohols and rinsed in distilled water for
five minutes.
Immunohistochemistry was performed using the Da-
koCytomation EnVision + System-HRP (AEC) kit from
Dako, following the manufacturer’s instructions. The sec-
tions were covered with peroxidase block reagent and in-
cubated for five minutes at room temperature, then rinsed
once in Phosphate Buffer Saline (PBS) pH 7.2, covered
with the antibody solution and incubated at 4°C overnight.
Rabbit Anti-Orphanin FQ Polyclonal Antibody (Chemi-
con) (1:500 dilution), Rabbit Anti-Oxytocin polyclonal
antibody (Chemicon) (1:800 dilution), Rabbit Anti-ANP
polyclonal antibody (Chemicon) (1:800 dilution), Mouse
Anti-eNOS/NOS type III monoclonal antibody (BD Bio-
sciences) (1:25 dilution) and Rabbit Anti-iNOS/NOS type
II polyclonal antibody (BD Biosciences) (1:25 dilution)
were used. As negative controls for our antibodies, we used
mouse IgG1 antibody (Dako, clone DAK-G01) (1:100 di-
lution) and rabbit immunoglobulin fraction (Dako) (1:200
dilution). All antibodies were diluted in a 0.1% bovine se-
rum albumin (BSA) solution.
Rat brains were used as positive controls for Orphanin
because of the well-documented expression of Orphanin in
the pituitary gland; the Rabbit Anti-Orphanin FQ Polyclonal
Antibody used was also able to recognize the rat protein.
Rat brains were also used as positive controls for Oxytocin,
since Oxytocin is expressed in the rat hypothalamus; the poly-
clonal antibody used in this study was able to recognize rat
Oxytocin. Rat hearts were used as positive controls for ANP,
since ANP is synthesized by atrial myocites; the polyclonal
antibody used was able to recognize rat ANP. Rat aorta was
used as positive control for eNOS, due to eNOS having en-
dothelial expression; the monoclonal antibody used also rec-
ognized rat protein. Human gingival mucosa samples from
patients with epulis were used as positive controls for iNOS
since epulis is characterized by inflammation and presence
of macrophages. Negative control sample was subjected to
the same treatment, but the primary antibody was omitted.
Samples were rinsed twice in PBS pH 7.2, incubated with
peroxidase-labeled polymer reagent for 30 minutes, rinsed
twice in PBS pH 7.2 and incubated with substrate-chro-
mogen reagent. The staining reaction was stopped by rins-
ing the slides in distilled water and the staining time was the
same for all the samples. Slides were coverslipped using the
DakoCytomation Faramount Aqueous Mounting Medium
(Dako, Glostrup, Denmark). The specimens were observed
under a Leica DM1000 light microscope.
Semi-quantitative evaluation of immunoreactivity. The
intensity of immunostaining showed in Table 1 was evaluat-
ed by three independent observers according to the follow-
ing criteria: (–) no staining, (+) light staining, (+ +) mod-
erate staining, (+ + +) intense staining.
Total RNA extraction. Samples of human umbilical cord
were frozen in liquid nitrogen immediately after cesarean
Table 1. Immunohistochemical results
Epithelium Wharton’s jelly Vessel musculature Endothelium
Orphanin – + + + + + +
Oxytocin + + + + – + + +
ANP + + + + + + – + + +
eNOS + + + + – +
iNOS – – – + + +
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section and stored at –80°C until use. Total RNA extraction
was accomplished using the Illustra RNAspin Mini Kit (Am-
ersham Biosciences, Milan) following the manufacturer’s
instructions; RNA yields were evaluated spectrophotomet-
rically (A260/A280) and RNA aliquots were stored at –80°C
until use.
RT-PCR (Reverse Transcription-Polymerase Chain Re-
action). For reverse transcription reaction, 2 μg of total
RNA was used; to avoid DNA contamination of RNA sam-
ples, DNAse digestion was performed using AMPD1 kit
(SIGMA). RT reaction was performed using the Enhanced
avian HS RT-PCR kit (SIGMA) following the manufactur-
er’s instructions: 1 μl random nonamers and 1 μl anchored
oligo (dT)23 were added to the DNAse digestion product
and incubated at 70°C for ten minutes to denature the sam-
ple, then 2 μl 10 × Buffer, 1 μl deoxynucleotide mix, 1 μl
RNAse inhibitor, 1 μl Enhanced AMV Reverse Tran-
scriptase enzyme and DEPC water were added to the sam-
ple. RT reaction was performed in 20 μl total volume at
42°C for 50 minutes, followed by a step at 95°C for five min-
utes to inactivate the enzyme.
PCR was performed using the PCR enzyme Selection
Kit — high specificity (Invitrogen) following the manufac-
turer’s instructions: 2 μl of template DNA, 0.5 μl of the prim-
ers mix (200 nM final concentration) and 22.5 μl of the Plat-
inum Super Mix were mixed together. The components were
denatured at 94°C for three minutes, then 40 cycles of 94°C
60 seconds, 56°C 60 seconds, 72°C 60 seconds, with a final
extension step at 72°C for ten minutes. Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) gene was used as in-
ternal positive control and PCR products were visualized
on 2% agarose gels stained with SYBR Green I nucleic acid
gel stain (SIGMA); a fluorescent DNA intercalating agent.
The sequences of the primers used in this work are shown
in Table 2.
Results
Orphanin FQ immunohistochemical expression was
widely spread in full-term human umbilical cord,
both in the stromal region and in the vascular com-
partment. The umbilical epithelium did not show
any reactivity for Orphanin antibody. On the con-
trary, Orphanin reactivity was evident in Wharton’s
jelly mesenchymal cells, being equally distributed
in all the thickness of the jelly, from the sub-epi-
thelial region to the blood vessel musculature. An
intense Orphanin protein expression was detected
in the endothelial cells of all three umbilical ves-
sels (Figure 2A), with intensity of immunoreaction
and staining features seemingly identical in arter-
ies and veins; in both cases brownish granules that
filled the cytoplasm and masked the nucleus could
be identified. Groups of muscle cells in vessel
smooth musculature showed a clear reactivity for
Orphanin antibody, particularly in the longitudi-
nal muscle layer.
Oxytocin reactivity was moderate in the epithelial
region with only part of the cells expressing the pep-
tide. In these positive cells, the distribution of stain-
ing granules in the cytoplasm contrasted the nuclear
negativity. Mesenchymal cells and fibroblasts in Whar-
ton’s jelly showed an intense immunoreactivity, with
typical brownish granules occupying the entire cyto-
plasm of the cells (Figure 2B). Vessel musculature
was negative for Oxytocin while endothelial cells were
highly reactive (Figure 2C).
ANP protein expression was evident in the umbil-
ical epithelium where many dark brown staining gran-
ules could be distinguished in the cytoplasm of the
epithelial cells. Wharton’s jelly cells showed an in-
tense reactivity in all the jelly tissue, from the sub-
Table 2. Names, sequences and amplification product size of PCR primers used in this work
Primer name Primer sequence Product size
Orphanin human forward GTC CTG CTT TGT GAC CTG CT 159 base pairs
Orphanin human reverse GCT GGG GAA GAC CTT CTC TT
Oxytocin human forward CGC CTG CTA CAT CCA GAA CT 193 base pairs
Oxytocin human reverse CGG CAG GTA GTT CTC CTC CT
ANP human forward GCT GGA CCA TTT GGA AGA AA 213 base pairs
ANP human reverse TTG CTT TTT AGG AGG GCA GA
eNOS human forward ACC CTC ACC GCT ACA ACA TC 198 base pairs
eNOS human reverse GCT CAT TCT CCA GGT GCT TC
iNOS human forward CCC AAG CTC TAC ACC TCC AA 284 base pairs
iNOS human reverse TCC AGG ATA CCT TGG ACC AG
GAPDH human forward GAG TCA ACG GAT TTG GTC GT 238 base pairs
GAPDH human reverse TTG ATT TTG GAG GGA TCT CG
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epithelial region to the vascular compartment (Fig-
ure 2D). An intense ANP reactivity was identified in
the arteries and vein endothelial cells (Figure 3A),
while the smooth muscle layers around vessels were
negative.
eNOS reactivity was evident in the umbilical epi-
thelium and in Wharton’s jelly cells, while being only
moderate in the endothelium (Figure 3B). In this case
smooth musculature around vessels also resulted neg-
ative. The distribution of positive cells in Wharton’s
jelly did not appear homogenous; the amount of fi-
broblasts expressing eNOS enzyme being higher in
the region immediately below the umbilical epitheli-
um, and decreasing in the inner jelly towards the ves-
sels (Figure 3C).
iNOS protein expression was detected only in the
endothelium of umbilical vessels; in endothelial cells
of both vein and arteries, the staining granules filled
the entire cytoplasm and the nuclei could not be dis-
tinguished (Figure 3D). The remaining regions of
umbilical cord did not express iNOS.
Figure 2. Immunohistochemistry in full-term human umbilical cord. A. Orphanin FQ in vascular endothelium (magnifi-
cation × 100, bar 100 μ); B. Oxytocin in Wharton’s jelly cells (× 100, bar 100 μ); C. Oxytocin in vascular endothelium (×
100, bar 100 μ); D. ANP in the umbilical epithelium and in Wharton’s jelly (× 20, bar 500 μ)
A B
C D
Table 1 summarizes the immunohistochemical re-
sults for all the five proteins investigated.
Transcriptional expression of the genes encoding
for these proteins was investigated through RT-PCR.
This revealed that Oxytocin, ANP and eNOS mRNAs
(Figure 4) were expressed in human umbilical cord,
confirming the immunohistochemical data, while
Orphanin and iNOS mRNAs were not detected.
Discussion
Orphanin FQ expression in human umbilical cord is
supported only by immunohistochemical data, while
RT-PCR did not detect mRNA expression for this
peptide. From this data, we could hypothesize that
the protein we identify through immunoreaction is
synthesized in another region of the body and deliv-
ered to the umbilical cord through the mother’s blood
flow. Interestingly, we found Orphanin protein ex-
pression mainly in the vascular compartment, in the
endothelium and in the longitudinal musculature of
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the vessels. In the literature, there have been many
studies concerning the role of Orphanin in vasore-
laxation: proinflammatory and vasodilatation effects
have been reported in the rat mesenteric microcircu-
lation and Orphanin relaxed the porcine coronary
arterial rings, as well as inhibiting PGF-2a-induced
vasocontractility [20–22]. The Orphanin expression
we identified in the vascular compartment of the
umbilical cord suggests a role for this peptide in the
regulation of vascular tone in this organ.
Oxytocin protein expression in the umbilical cord
was mainly localized in the mesenchymal cells of
Wharton’s jelly and in the vessel endothelium; the
immunohistochemical data was also confirmed by RT-
PCR analysis showing transcriptional expression of
the Oxytocin gene. In previous studies reported in
the literature, Oxytocin has been shown to play an
important role in the regulation of the vascular com-
partment: it causes vasodilatation in the pre-constrict-
ed pulmonary vasculature [23] and induces renal vas-
oconstriction in rats by activating vasopressin V1A
receptors [24]. Moreover, pharmacological studies
have shown the existence of Oxytocin receptors in
human umbilical vein endothelial cells (HUVEC); the
interaction between Oxytocin and its receptor causes
A B
C D
Figure 3. Immunohistochemistry in full-term human umbilical cord: A. ANP in vascular endothelium (× 100, bar 100 μ);
B. eNOS in vascular endothelium (× 100, bar 100 μ); C. eNOS in the amniotic epithelium of the umbilical cord and in
some cells of the sub-amniotic zone (× 20, bar 500 μ); D. iNOS in vascular endothelium (× 100, bar 100 μ)
Figure 4. RT-PCR analysis in full-term human umbilical cord.
Lane 1: GAPDH amplification product (238 base pairs); lane 2:
no amplification product for Orphanin FQ; lane 3: 100 bp
DNA ladder, from 1,000 base pairs to 200; lane 4: Oxytocin
amplification product (193 base pairs); lane 5: no amplification
product for iNOS; lane 6: ANP amplification product (213 base
pairs); lane 7: eNOS amplification product (198 base pairs)
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an increase in the intracellular levels of calcium, acti-
vating the pathway responsible for nitric oxide pro-
duction, thus leading to vasodilatation [25]. We hy-
pothesize that Oxytocin exerts its role on these cells
through an autocrine mechanism: the peptide  is syn-
thesized by HUVEC and acts on cell membrane Ox-
ytocin receptors, starting the cascade of events that
lead to NO production, release and finally to vasodi-
latation.
Oxytocin is typically synthesized by the hypothal-
amus, but some authors have demonstrated that it
can also be produced by other tissues, for example
the prostate gland [26]. The Oxytocin protein and
gene expression we detected in the endothelium of
umbilical cord vessels is in agreement with these re-
sults, and suggests that this peptide may also be syn-
thesized by endothelial cells.
Atrial Natriuretic Peptide (ANP) immunoreactiv-
ity was localized mainly in the vessel endothelium and
in Wharton’s jelly cells. In spite of the well-known
role of ANP in the regulation of muscle contractility,
we did not detect ANP expression in the vascular
musculature. RT-PCR confirmed ANP gene expres-
sion in the umbilical cord, suggesting that this pep-
tide is synthesized by umbilical cord cells. Previous
studies have demonstrated the expression of ANP in
HUVEC [27, 28], where it has anti-inflammatory ef-
fects, reduces tumor necrosis factor-alpha (TNF-al-
pha)-induced activation and induces HUVEC survival
in vitro [29, 30]. Other studies reported the co-loca-
lization of ANP with other vasoactive substances such
as neuropeptide Y (NPY), vasoactive intestinal pep-
tide (VIP), substance P, calcitonin gene-related pep-
tide (CGRP) and vasopressin [28] in umbilical ves-
sels endothelium, suggesting ANP could be involved
in a general mechanism of vascular homeostasis. Tem-
pleton et al. showed that physiological levels of ANP
significantly reduced the vasoconstrictor effects of 5-
hydroxytryptamine and endothelin-1 in the human
umbilical artery. This suggests that ANP may modify
vascular tone in vivo, thereby counterbalancing sev-
eral humoral factors which act to increase vascular
resistance within the fetoplacental circulation [31].
The expression of ANP in umbilical vessels endothe-
lium we detected could contribute to vasodilator/vas-
oconstriction effects, and thus to the regulation of
vascular tone.
Surprisingly, immunoreactivity for endothelial
Nitric Oxide Synthase (eNOS) was moderate in the
endothelium, while its expression resulted more evi-
dently in Wharton’s jelly mesenchymal cells. We also
detected eNOS gene transcriptional expression
through RT-PCR analysis, suggesting that eNOS is
synthesized by umbilical cord cells. In agreement with
our data, eNOS expression, typical of endothelia, has
also been reported in other types of tissues and cells,
such as many epithelium, fibroblasts, cardiomyocytes,
osteocytes and glial cells [32–35].
iNOS expression in the human umbilical cord was
detected only through immunohistochemistry, while RT-
PCR analysis gave a negative result. We think that this
discrepancy could mean that iNOS is synthesized in
another region and then delivered to the umbilical cord
through the mother’s blood flow. iNOS protein expres-
sion was mainly localized in the endothelium; the nitric
oxide synthesized by iNOS in the endothelium of um-
bilical vessels could contribute to vasodilatation and to
the regulation of vascular homeostasis. In agreement
with our findings, the expression of iNOS in HUVEC
cells has been reported by many authors [36].
In conclusion, our study identified through immu-
nohistochemistry the presence of Orphanin, Oxyto-
cin, ANP, eNOS and iNOS proteins in full-term hu-
man umbilical cord, where stromal and endothelial
compartments seem to be the main sources of these
vasoactive peptides. Moreover, RT-PCR showed tran-
scriptional expression of the genes encoding for Oxy-
tocin, ANP and eNOS, suggesting that these mole-
cules are synthesized by umbilical cord cells them-
selves, while Orphanin and iNOS are probably syn-
thesized in other regions and delivered to the
umbilical cord via the circulation.
The expression of these five vasoactive molecules
in the human umbilical cord could be part of a gener-
al mechanism, realized mainly by endothelial cells,
aimed at the local regulation of vascular tone, func-
tion and homeostasis of umbilical vessels.
It is already known that during trophoblast inva-
sion into the basal decidua, an increase of diastolic
flow occurs into the umbilical arteries. In this and in
the following phases of gestation, it has been demon-
strated that there is an increase in the expression of
vasoactive peptides. Bloodstream evaluation in the
uterus-placenta and fetus-placenta circulation
(fluximetry), routine today in gestational clinical prac-
tise, shows the importance that vasoactive peptides
can have on the homeostasis of the blood flow and
thus on the health of the fetus [37].
The importance of vasoactive peptides in gesta-
tion is  also highlighted by several fetal pathologies
related to the phenomena of hypoxia and asphyxia,
and by the intrauterine growth restriction syndrome
(IUGR) that is often associated with an increase of
resistance in one of the umbilical arteries.
Knowledge of the expression and distribution of
these vasoactive peptides in the umbilical cord may
help in understanding the histopathology of the feto-
placental system and could have important clinical
applications in the management of various syndromes
that can develop during pregnancy or delivery.
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